| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12185-012-1022-0 |
| P698 | PubMed publication ID | 22351163 |
| P2093 | author name string | Serkan Celik | |
| Cagatay Oktenli | |||
| Ozkan Sayan | |||
| Yavuz S Sanisoglu | |||
| Osman Ipcioglu | |||
| Fatih Tangi | |||
| H Onur Ozari | |||
| Alev A Erikci | |||
| Emrah Kilicaslan | |||
| M Hakan Terekeci | |||
| P2860 | cites work | PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-kappa B | Q24292156 |
| The PAAD/PYRIN-only protein POP1/ASC2 is a modulator of ASC-mediated nuclear-factor-kappa B and pro-caspase-1 regulation | Q24298443 | ||
| The PAAD/PYRIN-family protein ASC is a dual regulator of a conserved step in nuclear factor kappaB activation pathways | Q24337186 | ||
| Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product | Q28180120 | ||
| Familial autoinflammatory diseases: genetics, pathogenesis and treatment | Q28266680 | ||
| Targeting NF-kappaB in hematologic malignancies | Q28299055 | ||
| Phenylarsine oxide blocks interleukin-1beta-induced activation of the nuclear transcription factor NF-kappaB, inhibits proliferation, and induces apoptosis of acute myelogenous leukemia cells | Q28373909 | ||
| The PYRIN connection: novel players in innate immunity and inflammation | Q30956847 | ||
| Nuclear factor kB as a target for new drug development in myeloid malignancies | Q33292635 | ||
| A candidate gene for familial Mediterranean fever | Q34065122 | ||
| Fire and ICE: the role of pyrin domain-containing proteins in inflammation and apoptosis. | Q34153664 | ||
| The spectrum of Familial Mediterranean Fever (FMF) mutations | Q34314032 | ||
| Chromosome and molecular abnormalities in myelodysplastic syndromes | Q34336409 | ||
| A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF-kappaB and enhanced IRF-3/STAT1 activation). | Q34465280 | ||
| NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs) | Q34560200 | ||
| Myelodysplastic syndromes: From pathogenesis and prognosis to treatment | Q35800910 | ||
| Deregulated NF-kappaB activity in haematological malignancies | Q36541023 | ||
| The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions | Q36624543 | ||
| Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome | Q36988558 | ||
| Is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? | Q37118170 | ||
| The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing | Q40146198 | ||
| The rate of MEFV gene mutations in hematolymphoid neoplasms | Q40357212 | ||
| High frequency of MEFV gene mutations in patients with myeloid neoplasm | Q40359750 | ||
| NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome | Q40362293 | ||
| Increased asymmetric dimethylarginine levels in young men with familial Mediterranean fever (FMF): is it early evidence of interaction between inflammation and endothelial dysfunction in FMF? | Q40409956 | ||
| Familial Mediterranean fever attacks do not alter functional and morphologic tissue Doppler echocardiographic parameters | Q40413693 | ||
| The rate of pyrin mutations in critically ill patients with systemic inflammatory response syndrome and sepsis: a pilot study. | Q40442030 | ||
| Familial Mediterranean fever (FMF) in Lebanon and Jordan: a population genetics study and report of three novel mutations | Q40490090 | ||
| Does immune activation continue during an attack-free period in familial Mediterranean fever? | Q40521033 | ||
| Targeted disruption of pyrin, the FMF protein, causes heightened sensitivity to endotoxin and a defect in macrophage apoptosis | Q40562330 | ||
| The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. | Q40621671 | ||
| Clinical versus genetic diagnosis of familial Mediterranean fever | Q40622322 | ||
| Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. | Q40626582 | ||
| Expression of constitutively active nuclear-kappa B RelA transcription factor in blasts of acute myeloid leukemia | Q42457853 | ||
| Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells | Q43757315 | ||
| Acquisition of FLT3 or N-ras mutations is frequently associated with progression of myelodysplastic syndrome to acute myeloid leukemia | Q44737477 | ||
| Targeting NF-kappaB activation via pharmacologic inhibition of IKK2-induced apoptosis of human acute myeloid leukemia cells. | Q45083325 | ||
| Ancient Missense Mutations in a New Member of the RoRet Gene Family Are Likely to Cause Familial Mediterranean Fever | Q56288694 | ||
| Oncogene mutation and prognosis in the myelodysplastic syndromes | Q73309760 | ||
| Methylation of the p15(INK4b) gene in myelodysplastic syndromes is frequent and acquired during disease progression | Q74412911 | ||
| Nuclear factor k B is activated in myelodysplastic bone marrow cells | Q74753350 | ||
| Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia | Q77459150 | ||
| Increased IkappaB kinase activity is associated with activated NF-kappaB in acute myeloid blasts | Q78306906 | ||
| P433 | issue | 3 | |
| P921 | main subject | myelodysplastic syndrome | Q954625 |
| P304 | page(s) | 285-290 | |
| P577 | publication date | 2012-02-18 | |
| P1433 | published in | International Journal of Hematology | Q6051416 |
| P1476 | title | Frequency of inherited variants in the MEFV gene in myelodysplastic syndrome and acute myeloid leukemia | |
| P478 | volume | 95 |
| Q51732335 | CBL mutation and MEFV single-nucleotide variant are important genetic predictors of tumor reduction in glucocorticoid-treated patients with chronic myelomonocytic leukemia. |
| Q52659306 | Chemotherapy-Colchicine Interaction in a Child with Familial Mediterranean Fever and Hodgkin Lymphoma. |
| Q37997663 | High frequency of inherited variants in the MEFV gene in patients with hematologic neoplasms: a genetic susceptibility? |
| Q34141506 | Increased frequency of Mediterranean fever gene variants in multiple myeloma |
| Q37068967 | Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents |
| Q40110559 | Periodic Fever, Aphthosis, Pharyngitis, and Adenitis Syndrome: Analysis of Patients From Two Geographic Areas. |
Search more.